Minimally invasive surgery for recurrent cervical or vaginal cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a minimally invasive surgery (using small incisions) to remove a pelvic tumor that has come back after treatment for vaginal or cervical cancer. It aims to see if this approach can safely remove the recurrence while avoiding more extensive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vaginal or cervical cancer that has come back (recurred) or not gone away after treatment.
- Your cancer type is one of these: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma (checked under a microscope).
- The recurrence is only in the central part of the pelvis, and the tumor is 5 cm or smaller on an MRI scan.
- You are 18 or older and in good enough health for surgery (with an ECOG performance status of 0, 1, or 2).
- You have not had any other type of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of performing a radical hysterectomy (removal of the uterus and surrounding tissue) for early-stage cervical cancer: minimally invasive surgery versus traditional open surgery. The goal is to find out which approach is safer and more effective for treating the cancer.
This trial tests whether doing surgery with small incisions (minimally invasive) instead of a large cut is safe and effective for advanced ovarian cancer after chemo. It may mean a faster recovery while still removing the cancer.
This study tests whether a less invasive type of hysterectomy (keyhole surgery) works well for women with very early-stage cervical cancer. It aims to find a safer, faster recovery option for low-risk tumors.
This trial tests how safe a specific minimally invasive surgery tool (an endoscopic stapler) is for people with early-stage cervical cancer. If you qualify, you would get surgery to remove the cervix area using a minimally invasive approach and the study will track safety outcomes.
This trial studies the results of a major surgery called pelvic exenteration for patients with advanced rectal or anal cancer that has spread to nearby tissues or bones but not to distant organs. The goal is to see how well the surgery works and how patients recover afterward.
This trial studies whether doing surgery using smaller incisions after chemotherapy works as well as a more traditional approach for certain people with stage IIIC–IV ovarian, fallopian tube, or primary peritoneal cancer. It may help reduce surgical trauma while aiming for effective tumor removal.
Hear when a new Cervical Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.